Search Results - Lowensteyn, Ilka, PhD

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The Challenges and Benefits of Cardiovascular Risk Assessment in Clinical Practice

    The Challenges and Benefits of Cardiovascular Risk Assessment in Clinical Practice by Grover, Steven A., MD, MPA, Lowensteyn, Ilka, PhD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Estimating the Benefits of Patient and Physician Adherence to Cardiovascular Prevention Guidelines: The MyHealthCheckup Survey

    Estimating the Benefits of Patient and Physician Adherence to Cardiovascular Prevention Guidelines: The MyHealthCheckup Survey by Grover, Steven, MD, MPA, FRCPC, Coupal, Louis, MSc, Kouache, Mohammed, MSc, Lowensteyn, Ilka, PhD, Marchand, Sylvie, RN, Campbell, Norman, MD, FRCPC

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Preventing cardiovascular disease among Canadians: Is the treatment of hypertension or dyslipidemia cost-effective?

    Preventing cardiovascular disease among Canadians: Is the treatment of hypertension or dyslipidemia cost-effective? by Grover, Steven, MD MPA FRCPC, Coupal, Louis, MSc, Lowensteyn, Ilka, PhD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia?

    Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia? by Grover, Steven A., MD MPA FRCPC, Coupal, Louis, MSc, Kaouache, Mohammed, MSc, Lowensteyn, Ilka, PhD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Determining the cost-effectiveness of preventing cardiovascular disease: Are estimates calculated over the duration of a clinical trial adequate?

    Determining the cost-effectiveness of preventing cardiovascular disease: Are estimates calculated over the duration of a clinical trial adequate? by Grover, Steven A., MD MPA FRCPC, Coupal, Louis, MSc, Lowensteyn, Ilka, PhD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Prevalence and Determinants of Insomnia Following a Myocardial Infarction

    Prevalence and Determinants of Insomnia Following a Myocardial Infarction by Costa, Deborah Da, PhD, Allman, Ava-Ann, PhD, Libman, Eva, Desormeau, Philip, BA, Lowensteyn, Ilka, PhD, Grover, Steven, MD, MPA

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: